Nicholas Investment Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-119,372
| Closed | -$12.4M | – | 191 |
|
|
2022
Q4 | $12.4M | Buy |
+119,372
| New | +$12.4M | 1.08% | 37 |
|
|
2021
Q1 | – | Sell |
-81,530
| Closed | -$7.15M | – | 190 |
|
|
2020
Q4 | $7.15M | Sell |
81,530
-14,746
| -15% | -$1.29M | 0.55% | 62 |
|
|
2020
Q3 | $7.33M | Buy |
+96,276
| New | +$7.33M | 0.79% | 47 |
|
|
2020
Q2 | – | Sell |
-26,302
| Closed | -$2.22M | – | 172 |
|
|
2020
Q1 | $2.22M | Buy |
+26,302
| New | +$2.22M | 0.43% | 91 |
|
|
2018
Q2 | – | Sell |
-17,548
| Closed | -$1.42M | – | 227 |
|
|
2018
Q1 | $1.42M | Sell |
17,548
-20,494
| -54% | -$1.66M | 0.1% | 210 |
|
|
2017
Q4 | $3.39M | Buy |
38,042
+213
| +0.6% | +$19K | 0.22% | 149 |
|
|
2017
Q3 | $3.52M | Sell |
37,829
-722
| -2% | -$67.2K | 0.24% | 137 |
|
|
2017
Q2 | $3.5M | Buy |
38,551
+4,176
| +12% | +$379K | 0.25% | 143 |
|
|
2017
Q1 | $3.02M | Sell |
34,375
-3,541
| -9% | -$311K | 0.21% | 174 |
|
|
2016
Q4 | $3.14M | Sell |
37,916
-21,745
| -36% | -$1.8M | 0.24% | 177 |
|
|
2016
Q3 | $5.52M | Buy |
59,661
+1,922
| +3% | +$178K | 0.37% | 77 |
|
|
2016
Q2 | $4.49M | Buy |
57,739
+21,467
| +59% | +$1.67M | 0.31% | 116 |
|
|
2016
Q1 | $2.99M | Buy |
36,272
+11,207
| +45% | +$924K | 0.22% | 190 |
|
|
2015
Q4 | $2.63M | Sell |
25,065
-19,521
| -44% | -$2.05M | 0.18% | 217 |
|
|
2015
Q3 | $4.7M | Buy |
44,586
+1,941
| +5% | +$204K | 0.34% | 112 |
|
|
2015
Q2 | $5.83M | Buy |
42,645
+635
| +2% | +$86.9K | 0.37% | 77 |
|
|
2015
Q1 | $5.24M | Buy |
+42,010
| New | +$5.24M | 0.33% | 100 |
|
|
2014
Q2 | – | Sell |
-25,639
| Closed | -$1.75M | – | 274 |
|
|
2014
Q1 | $1.75M | Sell |
25,639
-9,297
| -27% | -$634K | 0.14% | 236 |
|
|
2013
Q4 | $2.46M | Sell |
34,936
-23
| -0.1% | -$1.62K | 0.19% | 164 |
|
|
2013
Q3 | $2.52M | Sell |
34,959
-5,160
| -13% | -$372K | 0.21% | 154 |
|
|
2013
Q2 | $2.24M | Buy |
+40,119
| New | +$2.24M | 0.21% | 158 |
|